AMCA
Arthur M. Cohen & Associates’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,458
| Closed | -$294K | – | 139 |
|
|
2024
Q3 | $294K | Sell |
4,458
-6,020
| -57% | -$397K | 0.05% | 113 |
|
|
2024
Q2 | $1.19M | Buy |
10,478
+636
| +6% | +$72.1K | 0.22% | 57 |
|
|
2024
Q1 | $1.37M | Sell |
9,842
-1,670
| -15% | -$232K | 0.29% | 48 |
|
|
2023
Q4 | $1.43M | Sell |
11,512
-340
| -3% | -$42.2K | 0.34% | 45 |
|
|
2023
Q3 | $1.11M | Sell |
11,852
-280
| -2% | -$26.1K | 0.28% | 53 |
|
|
2023
Q2 | $1.56M | Sell |
12,132
-350
| -3% | -$45K | 0.39% | 42 |
|
|
2023
Q1 | $1.45M | Sell |
12,482
-360
| -3% | -$41.8K | 0.39% | 39 |
|
|
2022
Q4 | $1.45M | Sell |
12,842
-390
| -3% | -$44.2K | 0.4% | 36 |
|
|
2022
Q3 | $1.07M | Buy |
13,232
+1,670
| +14% | +$135K | 0.29% | 49 |
|
|
2022
Q2 | $862K | Buy |
11,562
+8,119
| +236% | +$605K | 0.21% | 59 |
|
|
2022
Q1 | $1.76M | Buy |
3,443
+327
| +10% | +$167K | 0.37% | 40 |
|
|
2021
Q4 | $1.67M | Buy |
3,116
+20
| +0.6% | +$10.7K | 0.31% | 48 |
|
|
2021
Q3 | $1.69M | Buy |
+3,096
| New | +$1.69M | 0.34% | 44 |
|